OmniScriptum

Implications of US gene Patent invalidation on Australia: Myriad Genetics, DNA sequence, United States and Trademark Office, Ovarian cancer, ... trade law, Monopoly, Australian Office

Name: Implications of US gene Patent invalidation on Australia: Myriad Genetics, DNA sequence, United States and Trademark Office, Ovarian cancer, ... trade law, Monopoly, Australian Office
Brand: OmniScriptum
SKU: 312c429fab67eb3876bc6c1c1a9d7596

1/1

Image of Implications of US gene Patent invalidation on Australia: Myriad Genetics, DNA sequence, United States and Trademark Office, Ovarian cancer, ... trade law, Monopoly, Australian Office

Amazon

Prices from

168.22

Featured

	€ 168.22	To Shop
	€ 168.22	To Shop
COMPARE ALL WEBSHOPS (2)

Description

Implications of US gene Patent invalidation on Australia: Myriad Genetics, DNA sequence, United States and Trademark Office, Ovarian cancer, ... trade law, Monopoly, Australian Office

Compare webshops (2)

Sort by:

€ 168.22

Description (0)

Implications of US gene Patent invalidation on Australia: Myriad Genetics, DNA sequence, United States and Trademark Office, Ovarian cancer, ... trade law, Monopoly, Australian Office